Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk-Reference-Cited by-同舟云学术

Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk

Published:2018-09-13 Issue:10 Volume:18 Page:1085-1094
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Ren Peipei¹,Cao Zhujun¹,Mo Ruidong¹,Liu Yuhan¹,Chen Lichang¹,Li Ziqiang¹,Zhou Tianhui¹,Lu Jie¹,Liu Yunye¹,Guo Qing¹,Chen Rong¹,Zhou Huijuan¹,Xiang Xiaogang¹,Cai Wei¹,Wang Hui¹,Bao Shisan²,Xu Yumin¹,Gui Honglian¹,Xie Qing¹

Affiliation:

1. Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2. Discipline of Pathology, the University of Sydney, Sydney, NSW, Australia

Funder

the Shanghai Three-Year Plan of the Clinical Skills and Innovations

the Three-year Action Plan of Public Health in Shanghai

the National Clinical Key Specialty Construction Project of China

the National Natural Science Foundation of China

the National Key Programs on Infectious Diseases of China

Publisher

Informa UK Limited

Subject